- Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
-
Rhee EJ
- KMID: 2531385
- Endocrinol Metab.
- 2022 Jun;37(3):415-429.
- doi: 10.3803/EnM.2022.304
The world is suffering from a rapid increase in the number of people with diabetes due to the increased prevalence of obesity and lengthened life span. Since the development of... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-Chain Fatty Acids Attenuate Renal Fibrosis and Enhance Autophagy of Renal Tubular Cells in Diabetic Mice Through the HDAC2/ULK1 Axis
-
Ma X, Wang Q
- KMID: 2531387
- Endocrinol Metab.
- 2022 Jun;37(3):432-443.
- doi: 10.3803/EnM.2021.1336
Background: This study investigated the effect of short-chain fatty acids (SCFAs) on diabetes in a mouse model. Methods: Autophagy in Akita mice and streptozocin (STZ)-induced diabetic C57BL/6 mice was determined by... -
- CITED
-
- Close
- SHARE
-
- Close
- Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs
-
Kim HJ, Kim SS, Song SH
- KMID: 2529649
- Korean J Intern Med.
- 2022 May;37(3):502-519.
- doi: 10.3904/kjim.2021.515
Diabetes has reached epidemic proportions, both in Korea and worldwide and is associated with an increased risk of chronic kidney disease and kidney failure (KF). The natural course of kidney... -
- CITED
-
- Close
- SHARE
-
- Close
- GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
-
Yu JH, Park SY, Lee DY, Kim NH, Seo JA
- KMID: 2531741
- Kidney Res Clin Pract.
- 2022 Mar;41(2):136-149.
- doi: 10.23876/j.krcp.22.001
With the emergence of various classes of blood glucose-lowering agents, choosing the appropriate drug for each patient is emphasized in diabetes management. Among incretin-based drugs, glucagon-like peptide 1 (GLP-1) receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
-
Jung CY, Yoo TH
- KMID: 2527714
- Diabetes Metab J.
- 2022 Mar;46(2):181-197.
- doi: 10.4093/dmj.2021.0329
Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD has failed to decline over the past... -
- CITED
-
- Close
- SHARE
-
- Close
- Hip Fracture Risk According to Diabetic Kidney Disease Phenotype in a Korean Population
-
Lee SE, Yoo J, Kim KA, Han K, Choi HS
- KMID: 2527145
- Endocrinol Metab.
- 2022 Feb;37(1):148-158.
- doi: 10.3803/EnM.2021.1315
Background: Diabetic kidney disease (DKD) is associated with an elevated risk of fractures. However, little is known about the association between proteinuric or non-proteinuric DKD and the risk of hip... -
- CITED
-
- Close
- SHARE
-
- Close
- EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation
-
Ha KB, Sangartit W, Jeong AR, Lee ES, Kim HM, Shim S, Kukongviriyapan U, Kim DK, Lee EY, Chung CH
- KMID: 2527141
- Endocrinol Metab.
- 2022 Feb;37(1):96-111.
- doi: 10.3803/EnM.2021.1305
Background: Diabetic nephropathy (DN) is characterized by albuminuria and accumulation of extracellular matrix (ECM) in kidney. Transforming growth factor-β (TGF-β) plays a central role in promoting ECM accumulation. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiolucent Pure Matrix Stones on Computed Tomography Scan, Arising in Patient with Type I Diabetes and Chronic Kidney Disease: A Case Report
-
Song YW, Kim Jh, Bang K, Shin JH, Kim KM, Jeong J
- KMID: 2524982
- Korean J Fam Med.
- 2022 Jan;43(1):86-89.
- doi: 10.4082/kjfm.20.0095
Kidney matrix stones are a rare form of calculi, which are challenging to diagnose. Matrix stones consist of a proteinaceous material which has a radiolucent appearance that might be overlooked... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus
-
Huang Q, Yang D, Deng H, Liang H, Zheng X, Yan J, Xu W, Liu X, Yao B, Luo S, Weng J
- KMID: 2525129
- Diabetes Metab J.
- 2022 Jan;46(1):93-103.
- doi: 10.4093/dmj.2020.0240
Background: Both type 1 diabetes mellitus (T1DM) and metabolic syndrome (MetS) are associated with an elevated risk of morbidity and mortality yet with increasing heterogeneity. This study primarily aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
-
Kong L, Wang H, Li C, Cheng H, Cui Y, Liu L, Zhao Y
- KMID: 2522730
- Diabetes Metab J.
- 2021 Nov;45(6):909-920.
- doi: 10.4093/dmj.2020.0168
Background: The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown... -
- CITED
-
- Close
- SHARE
-
- Close
- Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
-
Huang HX, Shen LL, Huang HY, Zhao LH, Xu F, Zhang DM, Zhang XL, Chen T, Wang XQ, Xie Y, Su JB
- KMID: 2522726
- Diabetes Metab J.
- 2021 Nov;45(6):868-879.
- doi: 10.4093/dmj.2020.0149
Background: Type 2 diabetes mellitus (T2DM) is characterized by elevated fasting glucagon and impaired suppression of postprandial glucagon secretion, which may participate in diabetic complications. Therefore, we investigated the associations... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea
-
Cho NJ, Kim DY, Kwon SH, Ha TW, Kim HK, Lee MR, Chun SW, Park S, Lee Ey, Gil HW
- KMID: 2524384
- Kidney Res Clin Pract.
- 2021 Sep;40(3):383-391.
- doi: 10.23876/j.krcp.21.015
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitor has been reported to have kidney-protective benefits. To elucidate how antidiabetic agents prevent diabetic kidney disease progression, it is important to investigate their effect on... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening Tools Based on Nomogram for Diabetic Kidney Diseases in Chinese Type 2 Diabetes Mellitus Patients
-
Wang G, Wang B, Qiao G, Lou H, Xu F, Chen Z, Chen S
- KMID: 2520853
- Diabetes Metab J.
- 2021 Sep;45(5):708-718.
- doi: 10.4093/dmj.2020.0117
Background: The influencing factors of diabetic kidney disease (DKD) in Chinese patients with type 2 diabetes mellitus (T2DM) were explored to develop and validate a DKD diagnostic tool based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Tetrahydrocurcumin Ameliorates Kidney Injury and High Systolic Blood Pressure in High-Fat Diet-Induced Type 2 Diabetic Mice
-
Sangartit W, Ha KB, Lee ES, Kim HM, Kukongviriyapan U, Lee EY, Chung CH
- KMID: 2519669
- Endocrinol Metab.
- 2021 Aug;36(4):810-822.
- doi: 10.3803/EnM.2021.988
Background: Activation of the intrarenal renin-angiotensin system (RAS) is implicated in the pathogenesis of kidney injury and hypertension. We aimed to investigate the protective effect of tetrahydrocurcumin (THU) on intrarenal... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of inflammation in diabetic kidney disease
-
Jung SW, Moon JY
- KMID: 2517794
- Korean J Intern Med.
- 2021 Jul;36(4):753-766.
- doi: 10.3904/kjim.2021.174
Diabetic kidney disease (DKD) has been the leading cause of chronic kidney disease for over 20 years. Yet, over these two decades, the clinical approach to this condition has not... -
- CITED
-
- Close
- SHARE
-
- Close
- Manifestation of rs1888747 polymorphisms in the FRMD3 gene in diabetic kidney disease and diabetic retinopathy in type 2 diabetes patients
-
Kreepala C, Panpruang P, Yodprom R, Piyajarawong T, Wattanavaekin K, Danjittrong T, Phuthomdee S
- KMID: 2520042
- Kidney Res Clin Pract.
- 2021 Jun;40(2):263-271.
- doi: 10.23876/j.krcp.20.190
Background: FRMD3 polymorphisms has suggested that they could be an alternative test to differentiate diabetic nephropathy (DN) from nondiabetic renal disease (NDRD) in type 2 diabetes mellitus (DM) patients. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
-
Choi MS, Jun JE, Park SW, Yoo JH, Ahn J, Kim G, Jin SM, Hur KY, Lee MK, Kim JH
- KMID: 2516337
- Diabetes Metab J.
- 2021 May;45(3):349-357.
- doi: 10.4093/dmj.2019.0211
Background: Cardiovascular autonomic neuropathy (CAN) is a common microvascular complication of diabetes and related to albuminuria in diabetic nephropathy (DN). Urinary N-acetyl-β-D-glucosaminidase (uNAG) is a renal tubular injury marker which... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiorenal Protection in Diabetic Kidney Disease
-
Lee JF, Berzan E, Sridhar VS, Odutayo A, Cherney DZ
- KMID: 2515453
- Endocrinol Metab.
- 2021 Apr;36(2):256-269.
- doi: 10.3803/EnM.2021.987
Over the last 5 years there have been many new developments in the management of diabetic kidney disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 (SGLT2) inhibitors were... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
-
Bae JH, Park EG, Kim S, Kim SG, Hahn S, Kim NH
- KMID: 2515465
- Endocrinol Metab.
- 2021 Apr;36(2):388-400.
- doi: 10.3803/EnM.2020.912
Background: To compare the renal effects of dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors on individual outcomes in patients with type 2 diabetes. Methods: We searched electronic databases... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Nutrition Therapy of Diabetic Nephropathy
-
Park S
- KMID: 2526180
- J Korean Diabetes.
- 2021 Mar;22(1):51-55.
- doi: 10.4093/jkd.2021.22.1.51
Diabetic nephropathy is a microvascular complication in diabetic patients and a major cause of endstage kidney disease. Proper blood sugar control and blood pressure management can delay progression of kidney... -
- CITED
-
- Close
- SHARE
-
- Close
